MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-CG-14-0029759
White Hope Pharmaceutical Private Limited
White Hope Pharmaceutical Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.32 Cr
▲ 35% YoY
Net loss · FY 2024
₹8.32 Lakh
Net margin -6.3%
EBITDA · FY 2024
-₹1.07 Lakh
EBITDA margin -0.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
5
As per MCA filings
Active GSTINs
1
GST registered
About White Hope Pharmaceutical Private Limited
Data last updated:
White Hope Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2015PTC265308. Its GSTIN is 22AABCW6652Q1ZU (Chhattisgarh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Siddharth Lunkad and Manoj Kumar Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 704 Building 6 Sanskruti Thakur Complex Elegant Builders Kandivali(East), Mumbai, Maharashtra, India – 400101.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.32 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net loss of ₹8.32 Lakh (net margin -6.3%) and EBITDA of -₹1.07 Lakh (EBITDA margin -0.8%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 38% over five years.
White Hope Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CG-14-0029759). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233MH2015PTC265308
Registration Number 265308
Incorporation Date 08 June 2015
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-CG-14-0029759
Recognitions & Rankings of White Hope Pharmaceutical
Contact details
White Hope Pharmaceutical Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 704 Building 6 Sanskruti Thakur Complex Elegant Builders Kandivali(East), Mumbai, Maharashtra, India – 400101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of White Hope Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
White Hope Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of White Hope Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of White Hope Pharmaceutical Private Limited, buy the company report.
Financials of White Hope Pharmaceutical Private Limited
FY 2025 filings availableWhite Hope Pharmaceutical Private Limited reported revenue of ₹1.32 Cr (up 35% YoY) for FY 2024.
Revenue · FY 2024
₹1.32 Cr ▲ 35%
Net loss · FY 2024
₹8.32 Lakh margin -6.3%
EBITDA · FY 2024
-₹1.07 Lakh margin -0.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 35%
3 years · compounded
▼ 27%
5 years · compounded
▲ 38%
EBITDA CAGR growth
1 year
▼ 118%
3 years · compounded
▼ 27%
5 years · compounded
▲ 28%
Revenue has grown at a compounded annual rate (CAGR) of 38% over five years, including 35% growth in the latest year. EBITDA fell 118% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.32 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.8% | ||||
| Net Profit Margin | -6.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of White Hope Pharmaceutical Private Limited, buy the company report.
Board of directors of White Hope Pharmaceutical Private Limited
White Hope Pharmaceutical has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siddharth Lunkad Also directs: Gsme Advisors Private Limited | Director | 08 Jun 2015 | 11 Years 4 Months | Current |
| Manoj Kumar Jain | Director | 08 Jun 2015 | 11 Years 4 Months | Current |
| Harshvardhan Lunkad | Director | 08 Jun 2015 | 11 Years 4 Months | Current |
| Aayan Lunkad | Director | 08 Jun 2015 | 11 Years 4 Months | Current |
| Abeer Lunkad | Director | 08 Jun 2015 | 11 Years 4 Months | Current |
Auditor
White Hope Pharmaceutical Private Limited is audited by BEGANI & BEGANI for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BEGANI & BEGANI | FY 2021 | 010779C |
Shareholding
The shareholding of White Hope Pharmaceutical Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of White Hope Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving White Hope Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for White Hope Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
White Hope Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22AABCW6652Q1ZU | Chhattisgarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of White Hope Pharmaceutical Private Limited, buy the company report.
Recent activity
White Hope Pharmaceutical Private Limited has 6 board changes on record since 2015: 5 appointments and 1 cessation. The latest: Prakash Chand Jain ceased to be Director on 09 Jul 2017.
AGM
White Hope Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
White Hope Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Prakash Chand Jain ceased to be Director.
Appointed
Aayan Lunkad was appointed as Director.
Appointed
Abeer Lunkad was appointed as Director.
Appointed
Harshvardhan Lunkad was appointed as Director.
Appointed
Manoj Kumar Jain was appointed as Director.
Appointed
Siddharth Lunkad was appointed as Director.
Incorporation
08 Jun 2015
White Hope Pharmaceutical Private Limited was registered on 08 Jun 2015 with Roc Mumbai I & aged 11 years 4 months as per MCA records.
Frequently asked questions
White Hope Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 June 2015 (11+ years old) and is registered under CIN U24233MH2015PTC265308.
White Hope Pharmaceutical has 5 current directors:
- Siddharth Lunkad - Director
- Manoj Kumar Jain - Director
- Harshvardhan Lunkad - Director
- Aayan Lunkad - Director
- Abeer Lunkad - Director
The latest financial statements of White Hope Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of White Hope Pharmaceutical is 22AABCW6652Q1ZU, registered in Chhattisgarh.
The CIN (Corporate Identification Number) of White Hope Pharmaceutical is U24233MH2015PTC265308. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
White Hope Pharmaceutical was incorporated on 08 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Prakash Chand Jain ceased to be Director on 09 Jul 2017. Aayan Lunkad was appointed as Director on 08 Jun 2015. Abeer Lunkad was appointed as Director on 08 Jun 2015. White Hope Pharmaceutical has 6 board changes on record in total.
Yes, White Hope Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-CG-14-0029759).
The registered office of White Hope Pharmaceutical is at Flat No. 704 Building 6 Sanskruti Thakur Complex Elegant Builders KandivaliEast, Mumbai, Maharashtra, India – 400101.
White Hope Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.